Obesity-driven endometrial cancer: Is weight loss the answer?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 7, 2013, Pages 791-794

  MacKintosh, M L ^a   Crosbie, E J ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BARIATRIC SURGERY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; HUMAN; INSULIN RESISTANCE; MORBID OBESITY; NOTE; OBESITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; WEIGHT REDUCTION;

BARIATRIC SURGERY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OBESITY; WEIGHT LOSS;

EID: 84877759117     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12106     Document Type: Note

References (16)

1. Cancer Research UK Cancer Statistics 2012. [http://info.cancerresearchuk. org/cancerstats/types/uterus/incidence/] Accessed 16 September 2012
2. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG,. Body mass index, hormone replacement therapy and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010; 19 (12): 3119-30.
3. Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 2010; 126: 692-702.
4. Crosbie EJ, Roberts C, Qian W, Swart AM, Kitchener HC, Renehan AG,. Body mass index does not influence post treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur J Cancer 2012; 48: 853-64.
5. Kaaks R, Lukanova A, Kurzer MS,. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomark Prev 2002; 11: 1531-43.
6. Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, et al. Molecular pathology of endometrial hyperplasia and carcinoma. Human Pathol 2001; 32: 569-77.
7. Furness S, Roberts H, Marjoribanks J, Lethaby A,. Hormone therapy in 'postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev 2012; 15: CD000402.
8. Khandekar MJ, Cohen P, Spiegelman BM,. Molecular mechanisms of cancer development in obesity. Nature Rev Cancer 2011; 11: 886-95.
9. Villavicencio A, Aguilar G, Argüello G, Dünner C, Gabler F, Soto E, et al. The effect of overweight and obesity on proliferation and activation of AKT and ERK in human endometrial. Gynecol Oncol 2010; 117: 96-102.
10. Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CF, Bahamondes L,. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women. Aust N Z J Obstet Gynaecol 2008; 48: 207-13.
11. Sjostrom L, Gummesson A, Sjöström CD, Narbro K, Peltonen M, Wedel H, et al. Swedish Obese Subjects Study. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009; 10: 653-62.
12. McCawley GM, Ferriss JS, Geffel D, Northup CJ, Modesitt SC,. Cancer in obese women: potential protective impact of bariatric surgery. J Am Coll Surg 2009; 208: 1093-8.
13. Adams TD, Stroup AM, Gress RE, Adams KF, Calle EE, Smith SC, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity 2009; 17: 796-802.
14. Ashrafian H, Ahmed K, Rowland SP, Patel VM, Gooderham NJ, Holmes E, et al. Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer 2011; 117: 1788-99.
15. Argenta PA, Kassing M, Truskinovsky AM, Svendsen CA,. Bariatric surgery and endometrial pathology in asymptomatic morbidly obese women: a prospective, pilot study. BJOG 2013; 120: 795-800.
16. Popat VC, Vora DN, Gadhvi NS, Bhanvadia VM, Madan YG,. Comparison of endometrial intraepithelial neoplasia with WHO endometrial hyperplasia classification system. A compariative study of 150 cases. Histopathology 2010; 57: 646-8.